Cargando…

Reticulocalbin 2 as a Potential Biomarker and Therapeutic Target for Atherosclerosis

Vascular inflammation initiated by oxidized lipoproteins drives initiation, progression, and even rupture of atherosclerotic plaques. Yet, to date, no biomarker is directly linked to oxidized lipid-induced vascular inflammation. Reticulocalbin 2 (RCN2) is a key regulator of basal and oxidized lipid-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jing, Taylor, Angela M., Manichaikul, Ani, Angle, John F., Shi, Weibin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997427/ https://www.ncbi.nlm.nih.gov/pubmed/35406670 http://dx.doi.org/10.3390/cells11071107

Ejemplares similares

Reticulocalbin-1 Facilitates Microglial Phagocytosis
por: Ding, Ying, et al.
Publicado: (2015)

Atherosclerosis Susceptibility Loci Identified in an Extremely Atherosclerosis‐Resistant Mouse Strain
por: Rowlan, Jessica S., et al.
Publicado: (2013)

Reticulocalbin 3 Is a Novel Mediator of Glioblastoma Progression
por: He, Yi, et al.
Publicado: (2023)

Data on genetic analysis of atherosclerosis identifies a major susceptibility locus in the major histocompatibility complex of mice
por: Grainger, Andrew T., et al.
Publicado: (2016)

Downregulation of reticulocalbin‐1 differentially facilitates apoptosis and necroptosis in human prostate cancer cells
por: Liu, Xiaofei, et al.
Publicado: (2018)

Reticulocalbin 3 is involved in postnatal tendon development by regulating collagen fibrillogenesis and cellular maturation
por: Park, Na Rae, et al.
Publicado: (2021)

Data on genetic linkage of oxidative stress with cardiometabolic traits in an intercross derived from hyperlipidemic mouse strains
por: Fuller, Daniela T., et al.
Publicado: (2020)

Reticulocalbin3: A Ca(2+) homeostasis regulator that promotes esophageal squamous cell carcinoma progression and cisplatin resistance
por: Cai, Rui, et al.
Publicado: (2022)

Differential Proteomics Identifies Reticulocalbin-3 as a Novel Negative Mediator of Collagen Production in Human Cardiac Fibroblasts
por: Martínez-Martínez, Ernesto, et al.
Publicado: (2017)

Bioinformatic identification of potential biomarkers and therapeutic targets in carotid atherosclerosis and vascular dementia
por: Li, Dongshi, et al.
Publicado: (2023)

EGFRvIII Promotes Cell Survival during Endoplasmic Reticulum Stress through a Reticulocalbin 1-Dependent Mechanism
por: Gomez, Juliana, et al.
Publicado: (2021)

Exosomes in atherosclerosis: performers, bystanders, biomarkers, and therapeutic targets
por: Wang, Chen, et al.
Publicado: (2021)

Reticulocalbin 1 is required for proliferation and migration of non‐small cell lung cancer cells regulated by osteoblast‐conditioned medium
por: Fu, Haijing, et al.
Publicado: (2021)

MicroRNAs as Therapeutic Targets and Clinical Biomarkers in Atherosclerosis
por: Solly, Emma L., et al.
Publicado: (2019)

Fibulin-1C, C1 Esterase Inhibitor and Glucose Regulated Protein 75 Interact with the CREC Proteins, Calumenin and Reticulocalbin
por: Aune Westergaard Hansen, Gry, et al.
Publicado: (2015)

Transcription Factor-7-Like-2 (TCF7L2) in Atherosclerosis: A Potential Biomarker and Therapeutic Target
por: Li, Junyi, et al.
Publicado: (2021)

Potential therapeutic targets for atherosclerosis in sphingolipid metabolism
por: Yu, Zemou, et al.
Publicado: (2019)

Genetic linkage of hyperglycemia and dyslipidemia in an intercross between BALB/cJ and SM/J Apoe-deficient mouse strains
por: Wang, Qian, et al.
Publicado: (2015)

Circadian Rhythm: Potential Therapeutic Target for Atherosclerosis and Thrombosis
por: Man, Andy W. C., et al.
Publicado: (2021)

Correction: Fibulin-1C, C1 Esterase Inhibitor and Glucose Regulated Protein 75 Interact with the CREC Proteins, Calumenin and Reticulocalbin
por: Aune Westergaard Hansen, Gry, et al.
Publicado: (2015)

New Insight in HDACs: Potential Therapeutic Targets for the Treatment of Atherosclerosis
por: Luan, Yi, et al.
Publicado: (2022)

Detailed analysis of association between common single nucleotide polymorphisms and subclinical atherosclerosis: The Multi-ethnic Study of Atherosclerosis
por: Vargas, Jose D., et al.
Publicado: (2016)

Interleukin-22: a potential therapeutic target in atherosclerosis
por: Luo, Jin-Wen, et al.
Publicado: (2021)

Histone Deacetylase 3: A Potential Therapeutic Target for Atherosclerosis
por: Jiang, Li-Ping, et al.
Publicado: (2022)

Sialic acid metabolism as a potential therapeutic target of atherosclerosis
por: Zhang, Chao, et al.
Publicado: (2019)

Function and Therapeutic Potential of Mesenchymal Stem Cells in Atherosclerosis
por: Li, Feifei, et al.
Publicado: (2017)

The regulation of immune cells by Lactobacilli: a potential therapeutic target for anti-atherosclerosis therapy
por: Ding, Ya-Hui, et al.
Publicado: (2017)

Piezo1 in vascular remodeling of atherosclerosis and pulmonary arterial hypertension: A potential therapeutic target
por: Xu, Han, et al.
Publicado: (2022)

TPM2 as a potential predictive biomarker for atherosclerosis
por: Meng, Ling-Bing, et al.
Publicado: (2019)

Developments in the Role of Endothelin-1 in Atherosclerosis: A Potential Therapeutic Target?
por: Sutton, Greg, et al.
Publicado: (2019)

Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis
por: Salazar, Juan, et al.
Publicado: (2022)

PAMPs and DAMPs as the Bridge Between Periodontitis and Atherosclerosis: The Potential Therapeutic Targets
por: Zhu, Xuanzhi, et al.
Publicado: (2022)

Caveolin-1 in endothelial cells: A potential therapeutic target for atherosclerosis
por: Shu, Yan, et al.
Publicado: (2023)

MD-2 as a possible therapeutic target for atherosclerosis
por: Chen, Shuang, et al.
Publicado: (2020)

Role of Endoplasmic Reticulum Stress in Atherosclerosis and Its Potential as a Therapeutic Target
por: Yang, Shengjie, et al.
Publicado: (2020)

MicroRNAs as Potential Biomarkers in Atherosclerosis
por: Churov, Alexey, et al.
Publicado: (2019)

Natural Monoterpenes as Potential Therapeutic Agents against Atherosclerosis
por: Yang, Jing, et al.
Publicado: (2023)

Identification of Three Cuproptosis-specific Expressed Genes as Diagnostic Biomarkers and Therapeutic Targets for Atherosclerosis
por: Chen, Yong-tong, et al.
Publicado: (2023)

Atherogenesis in Apoe(−/−) and Ldlr(−/−) Mice with a Genetically Resistant Background
por: Torikai, Hideyuki, et al.
Publicado: (2023)

Inflammation as a Therapeutic Target in Atherosclerosis
por: Nguyen, Mau T, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_opb9mltvgfn0bjnejd5fcbr2b3